(5alpha,8alpha)-ergotaman (34612-42-5)

Identification
Name:	(5alpha,8alpha)-ergotaman
Synonyms:	ergotaman;AC1L4AHZ;CHEBI:36185;34612-42-5
CAS:	34612-42-5
Molecular Formula:	C₂₅H₃₃N₅O
Molecular Weight:	419.5624
InChI:	InChI=1/C25H33N5O/c1-28-14-16(10-19-18-4-2-5-20-24(18)17(13-26-20)11-22(19)28)12-27-23-15-30-9-8-29-7-3-6-21(29)25(30)31-23/h2,4-5,10,13,16,21-23,25-27H,3,6-9,11-12,14-15H2,1H3/t16-,21-,22+,23+,25-/m0/s1
Molecular Structure:
Properties
Flash Point:	338.6°C
Boiling Point:	636.2°C at 760 mmHg
Density:	1.33g/cm³
Refractive index:	1.711
Flash Point:	338.6°C
Safety Data

Other Product

(5alpha,8alpha)-12'-hydroxy-3',6',18-trioxoergotaman
1,4:5,8-Dimethanonaphthalene, decahydro-, (1alpha,4alpha,4aalpha,5alpha,8alpha,8aalpha)-
1,4:5,8-Dimethanonaphthalene, 1,2,3,4,5,8-hexahydro-, (1alpha,4alpha,5alpha,8alpha)-
1,4:5,8-Dimethanonaphthalene, 1,2,3,4,5,6,7,8-octahydro-, (1alpha,4alpha,5alpha,8alpha)-
(5alpha,8alpha)-3-methoxy-17-methyl-4,5-epoxymorphinan-8-ol
Ergotaman-3,6,18-trione, 12-hydroxy-2-methyl-5-(phenylmethyl)-, (5alpha)-, (2Z)-2-butenedioate (salt)
(5alpha,8alpha,9alpha)-2-chloro-5,8,9,10-tetrahydro-5,9-methanobenzocycloocten-8-ylammonium chloride
(5alpha,8alpha)-3-methoxy-17-methyl-4,5-epoxymorphinan-8-yl acetate
(5alpha,8alpha)-3-hydroxy-17-methyl-6,7-didehydro-4,5-epoxymorphinan-8-yl acetate
(5alpha,8alpha)-3-methoxy-17-methyl-6,7-didehydro-4,5-epoxymorphinan-8-ol hydrochloride
1,4:5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexachloro-1,4,4a,5,6,7,8,8a,-octahydro-, (1alpha,4a,4abeta,5alpha,8alpha,8abeta)-
1,4:5,8:9,10-Trimethanoanthracene, 1,2,3,4,4a,5,8,8a,9,9a,10,10a-dodecahydro-(1alpha,4alpha,4aalpha,5alpha,8alpha,8aalpha,9beta,9aalpha,10beta,10aalpha)-
1,4:5,8:9,10-Trimethanoanthracene, 1,4,4a,5,8,8a,9,9a,10,10a-decahydro-(1alpha,4alpha,4aalpha,5alpha,8alpha,8aalpha,9beta,9aalpha,10beta,10aalpha)-
(2Z)-2-[(3alpha,4alpha,5alpha,6alpha,7beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-bis(acetyloxy)-3,7-dihydroxy-4,8,10,14-tetramethylgonan-17-ylidene]-6-methylhept-5-enoic acid
Naphtho(2,3-d)-1,3-dioxole-6-carboxylic acid, 5,6,7,8-tetrahydro-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-, 2-ethylhydrazide, (5R-(5alpha,6alpha,7beta,8alpha))- (9CI)
ethanesulfonic acid, 2-[[(2Z)-2-[(3alpha,4alpha,5alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-16-acetyl-3,11-dihydroxy-4,8,10,14-tetramethylgonan-17-ylidene]-6-methyl-1-oxoheptyl]amino]-, monosodium salt
Ergotaman-3,6,18-trione, 9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl)-, (5alpha,10alpha)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (2:1) (salt), mixt. with (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol phosphate (1:1) (salt), 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
8alpha-N-Imidazolylriboflavin
(8alpha)-6,8-dimethylergoline
8alpha-Amino-6-methylergoline